Cristian Massacesi sold $403k of BMY
EVP,Chief Med Offr,Head of Dev at BRISTOL MYERS SQUIBB CO. 6,249 shares at an average of $64.57, traded Sep 9, 2026, filed Sep 10, 2026.
Score components
- +15RoleOfficer
- +16Trade size$403k at market
- +5Share of holdings soldSold 25% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002080176-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | SOpen-market sale Common Stock, $0.10 par value | -6,249 | $64.57 | $403k | 18,748 | 32 d ago |
Related signals
Other insiders at BRISTOL MYERS SQUIBB CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | BMYsell BRISTOL MYERS SQUIBB CO | Benjamin Hickey President, RayzeBio Org. | $3,702 97 shares | -100% | |
| 49Moderate | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $202k 4,250 shares | +5% | |
| 43Moderate | BRISTOL MYERS SQUIBB CO | Christopher S. Boerner Chief Executive Officer | $110k 2,000 shares | +2% | |
| 33Weak | BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,823 shares | +3% | |
| 25Weak | BMYbuy BRISTOL MYERS SQUIBB CO | Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. | $100k 1,830 shares | +3% | |
| 21Weak | BMYsell BRISTOL MYERS SQUIBB CO | Phil M Holzer SVP and Controller | $39k 700 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.